Patents by Inventor Charles H. Bowden

Charles H. Bowden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
    Publication number: 20240139224
    Abstract: This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from sleep apnea, including obstructive sleep apnea syndrome (OSAS). Treatment is effected by administering a carbonic anhydrase inhibitor to the patient in combination with an aldosterone antagonist. Formulations containing a therapeutically effective amount of a carbonic anhydrase inhibitor and a therapeutically effective amount of an aldosterone antagonist are provided as well.
    Type: Application
    Filed: January 12, 2024
    Publication date: May 2, 2024
    Inventors: Charles H. BOWDEN, Craig PETERSON
  • TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
    Publication number: 20210161932
    Abstract: This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from sleep apnea, including obstructive sleep apnea syndrome (OSAS). Treatment is effected by administering a carbonic anhydrase inhibitor to the patient in combination with an aldosterone antagonist. Formulations containing a therapeutically effective amount of a carbonic anhydrase inhibitor and a therapeutically effective amount of an aldosterone antagonist are provided as well.
    Type: Application
    Filed: February 16, 2021
    Publication date: June 3, 2021
    Inventors: Charles H. BOWDEN, Craig PETERSON
  • TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
    Publication number: 20200069716
    Abstract: This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from sleep apnea, including obstructive sleep apnea syndrome (OSAS). Treatment is effected by administering a carbonic anhydrase inhibitor to the patient in combination with an aldosterone antagonist. Formulations containing a therapeutically effective amount of a carbonic anhydrase inhibitor and a therapeutically effective amount of an aldosterone antagonist are provided as well.
    Type: Application
    Filed: March 8, 2019
    Publication date: March 5, 2020
    Inventors: Charles H. BOWDEN, Craig PETERSON
  • TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
    Publication number: 20160045527
    Abstract: This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from sleep apnea, including obstructive sleep apnea syndrome (OSAS). Treatment is effected by administering a carbonic anhydrase inhibitor to the patient in combination with an aldosterone antagonist. Formulations containing a therapeutically effective amount of a carbonic anhydrase inhibitor and a therapeutically effective amount of an aldosterone antagonist are provided as well.
    Type: Application
    Filed: August 13, 2015
    Publication date: February 18, 2016
    Inventors: Charles H. Bowden, Craig Peterson
  • TREATMENT OF OBSTRUCTIVE SLEEP APNEA SYNDROME WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ADDITIONAL ACTIVE AGENT
    Publication number: 20150231110
    Abstract: This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from obstructive sleep apnea syndrome (OSAS). Treatment of OSAS is effected by administering a carbonic anhydrase inhibitor to the patient in combination with at least one additional active agent. Examples of additional active agents include modafinil, eszopiclone, zolpidem, zaleplon, and phentermine.
    Type: Application
    Filed: May 6, 2015
    Publication date: August 20, 2015
    Inventors: Leland F. Wilson, Peter Y. Tam, Thomas Najarian, Charles H. Bowden
  • Treatment of Obstructive Sleep Apnea Syndrome with a Combination of a Carbonic Anhydrase Inhibitor and an Additional Active Agent
    Publication number: 20140094511
    Abstract: This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from obstructive sleep apnea syndrome (OSAS). Treatment of OSAS is effected by administering a carbonic anhydrase inhibitor to the patient in combination with at least one additional active agent. Examples of additional active agents include modafinil, eszopiclone, zolpidem, zaleplon, and phentermine.
    Type: Application
    Filed: October 17, 2013
    Publication date: April 3, 2014
    Applicant: Vivus, Inc.
    Inventors: Leland F. Wilson, Peter Y. Tam, Thomas Najarian, Charles H. Bowden
  • TREATMENT OF OBSTRUCTIVE SLEEP APNEA SYNDROME WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ADDITIONAL ACTIVE AGENT
    Publication number: 20110224196
    Abstract: This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from obstructive sleep apnea syndrome (OSAS). Treatment of OSAS is effected by administering a carbonic anhydrase inhibitor to the patient in combination with at least one additional active agent. Examples of additional active agents include modafinil, eszopiclone, zolpidem, zaleplon, and phentermine.
    Type: Application
    Filed: January 7, 2011
    Publication date: September 15, 2011
    Applicant: Vivus, Inc.
    Inventors: Leland F. Wilson, Peter Tam, Thomas Najarian, Charles H. Bowden
  • Medical sensor with modulated encoding scheme
    Patent number: 6044283
    Abstract: The present invention provides an encoding mechanism for a medical sensor which uses a modulated signal to provide the coded data to a remote analyzer. The modulated signal could be, for instance, a pulse width modulated signal or a frequency modulated signal. This signal is amplitude independent and thus provides a significant amount of noise immunity.
    Type: Grant
    Filed: May 6, 1998
    Date of Patent: March 28, 2000
    Assignee: Nellcor Puritan Bennett Incorporated
    Inventors: Michael E. Fein, David C. Jenkins, Michael J. Bernstein, K. L. Venkatachalam, Adnan I. Merchant, Charles H. Bowden
  • Medical sensor with modulated encoding scheme
    Patent number: 5779630
    Abstract: The present invention provides an encoding mechanism for a medical sensor which uses a modulated signal to provide the coded data to a remote analyzer. The modulated signal could be, for instance, a pulse width modulated signal or a frequency modulated signal. This signal is amplitude independent and thus provides a significant amount of noise immunity.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: July 14, 1998
    Assignee: Nellcor Puritan Bennett Incorporated
    Inventors: Michael E. Fein, David C. Jenkins, Michael J. Bernstein, K. L. Venkatachalam, Adnan I. Merchant, Charles H. Bowden
  • Medical sensor with modulated encoding scheme
    Patent number: 5645059
    Abstract: The present invention provides an encoding mechanism for a medical sensor which uses a modulated signal to provide the coded data to a remote analyzer. The modulated signal could be, for instance, a pulse width modulated signal or a frequency modulated signal. This signal is amplitude independent and thus provides a significant amount of noise immunity.
    Type: Grant
    Filed: December 17, 1993
    Date of Patent: July 8, 1997
    Assignee: Nellcor Incorporated
    Inventors: Michael E. Fein, David C. Jenkins, Michael J. Bernstein, K. L. Venkatachalam, Adnan I. Merchant, Charles H. Bowden